Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: FCP
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: International

Carnegie Fund V - The Carnegie Global Healthcare Fund

+ Add to Watchlist

CARGLHL:LX

348.59 EUR 3.50 1.01%

As of 00:59:30 ET on 03/04/2015.

Snapshot for Carnegie Fund V - The Carnegie Global Healthcare Fund (CARGLHL)

Year To Date: +19.68% 3-Month: +32.50% 3-Year: +32.95% 52-Week Range: 185.21 - 348.92
1-Month: +13.63% 1-Year: +48.27% 5-Year: +23.86% Beta vs RGUSHS: 0.93

Mutual Fund Chart for CARGLHL

No chart data available.
  • CARGLHL:LX 348.59
  • 1M
  • 1Y
Interactive CARGLHL Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for CARGLHL

Carnegie Fund V - The Carnegie Global Healthcare Fund is an FCP incorporated in Luxembourg. The Fund's objective is capital appreciation. The Fund invests exclusively in equity securities of the healthcare industry. The Fund primarily invests in companies with a market capitalisation of less than one billion US dollars and which generate 50% of their profits from healthcare.

Inception Date: 08-31-1998 Telephone: Not Disclosed
Managers: MIKAEL SVENSSON
Web Site: www.carnegieam.com

Fundamentals for CARGLHL

NAV (on 2015-03-04) 348.59
Assets (M) (on 2015-02-27) 135.26
Fund Leveraged N
Minimum Investment 1,000.00
Minimum Subsequent Investment -

Dividends for CARGLHL

No dividends reported

Fees & Expenses for CARGLHL

Front Load 0.00
Back Load 1.00
Current Mgmt Fee 2.00
Redemption Fee 1.00
12b1 Fee -
Expense Ratio 1.10

Top Fund Holdings for CARGLHL

Filing Date: 01/30/2015
Name Position Value % of Total
Isis Pharmaceuticals Inc 101,880 6,322,570 5.184%
Salix Pharmaceuticals Ltd 41,955 5,052,448 4.143%
ABIOMED Inc 104,888 4,852,009 3.978%
Jazz Pharmaceuticals PLC 30,767 4,693,008 3.848%
DexCom Inc 79,925 4,290,658 3.518%
Cempra Inc 168,584 4,167,262 3.417%
Auspex Pharmaceuticals Inc 70,921 3,785,339 3.104%
Keryx Biopharmaceuticals Inc 329,700 3,749,838 3.075%
Cepheid 73,421 3,721,374 3.051%
Spectranetics Corp/The 123,956 3,683,490 3.020%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil